Elizabeth Ingram
Algemeen Directeur bij Cipla Therapeutics, Inc.
Profiel
Elizabeth G.
Ingram is currently the President & Chief Executive Officer at Cipla Therapeutics, Inc. She previously served as an Independent Director at Avenue Therapeutics, Inc. from 2019 to 2022.
Prior to that, she was the Vice President-Market Access Strategy at Bristol Myers Squibb Co. from 2012 to 2014.
Elizabeth also held the position of Chief Marketing Officer at MannKind Corp.
in 2018 and was the Senior Vice President-Managed Market at DexCom, Inc. in 2017.
She completed her undergraduate degree at East Carolina University and her graduate degree at the University of South Carolina.
Actieve functies van Elizabeth Ingram
| Bedrijven | Functie | Begin |
|---|---|---|
| Cipla Therapeutics, Inc. | Algemeen Directeur | - |
Eerdere bekende functies van Elizabeth Ingram
| Bedrijven | Functie | Einde |
|---|---|---|
| AVENUE THERAPEUTICS, INC. | Directeur/Bestuurslid | 31-10-2022 |
| MANNKIND CORPORATION | Verkoop & Marketing | 01-06-2019 |
| DEXCOM, INC. | Corporate Officer/Principal | 01-12-2017 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-01-2014 |
Opleiding van Elizabeth Ingram
| East Carolina University | Undergraduate Degree |
| University of South Carolina | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| MANNKIND CORPORATION | Health Technology |
| DEXCOM, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| AVENUE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
| Cipla Therapeutics, Inc. |
